Filters

LDL Antibody

LDL Antibody size: 0.1ml 263

Price 263
Size 0.1ml
Long nameLDL Primary Polyclonal Antibody
Also known asLDL PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenLDL
SpecificityThis is a highly specific antibody against LDL
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceFull length plasma protein (Human)
Gene ID number348
Swiss ProtP02649
Tested Applications IF(IHC-P), IHC-P, ELISA
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), ELISA(1:500-1000)
Cross reactivity Mouse, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen It can serve as a ligand for the LDL (apo B/E) receptor and for the specific apo-E receptor (chylomicron remnant) of hepatic tissues, and catabolism of lipoprotein particles, internalization, Mediates the binding
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names APO-E, APOE, Apolipoprotein E, LDLCQ5, LPG, AD2
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetLDL
Short nameLDL Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameLDL (Antibody to)
Alternative techniqueantibodies
Identity 31708
Gene LRP12
Long gene name LDL receptor related protein 12
Synonyms gene name low density lipoprotein receptor-related protein 12
Synonyms ST7 FLJ12929
Locus 8q22, 3
Discovery year 2004-07-06
GenBank acession AF166350
Entrez gene record 29967
Pubmed identfication 12809483 14676824
RefSeq identity NM_013437
Classification Low density lipoprotein receptors
Havana BLAST/BLAT OTTHUMG00000164892

Subscribe to our Newsletter